Literature DB >> 22243731

Phaeohyphomycosis caused by Phaeoacremonium species in a patient taking infliximab.

Jason D Mazzurco, James Ramirez, David P Fivenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22243731     DOI： 10.1016/j.jaad.2010.04.015

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.

Authors:  Hamid Badali; Sadegh Khodavaisy; Hamed Fakhim; G Sybren de Hoog; Jacques F Meis; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

Review 2.  Dual Invasive Infection with Phaeoacremonium parasiticum and Paraconiothyrium cyclothyrioides in a Renal Transplant Recipient: Case Report and Comprehensive Review of the Literature of Phaeoacremonium Phaeohyphomycosis.

Authors:  Marie-Alice Colombier; Alexandre Alanio; Blandine Denis; Giovanna Melica; Dea Garcia-Hermoso; Bénédicte Levy; Marie-Noëlle Peraldi; Denis Glotz; Stéphane Bretagne; Sébastien Gallien
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

3.  Pulmonary phaeohyphomycosis caused by phaeoacremonium in a kidney transplant recipient: successful treatment with posaconazole.

Authors:  Saivaralaxmi Monaganti; Carlos A Q Santos; Andrea Markwardt; Morgan A Pence; Daniel C Brennan
Journal:  Case Rep Med       Date:  2014-05-14

4.  Phaeoacremonium parasiticum phaeohyphomycosis in a patient with systemic lupus erythematosus treated successfully with surgical debridement and voriconazole: A case report and review of the literature.

Authors:  Rima I El-Herte; Katie E Schouweiler; Ronda S Farah; Ricardo Arbulu; Daniel Diekema; Karolyn A Wanat; Bradley A Ford
Journal:  IDCases       Date:  2014-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.